INGRID BLAIR: Open Payments
NPI 1427313121 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 43 payments from 8 companies in 2025. Trend: 2023 $311 · 2024 $1,288 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $370 |
| Alkermes, Inc. | 6 | $351 |
| E.R. Squibb & Sons, L.L.C. | 15 | $216 |
| Teva Pharmaceuticals USA, Inc. | 4 | $204 |
| Janssen Pharmaceuticals, Inc | 4 | $167 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: VRAYLAR, LYBALVI, COBENFY, INVEGA SUSTENNA, UZEDY, ARISTADA, AUSTEDO XR, REXULTI.
Industry payments across MI — which companies pay providers there.
